vs
CITIUS ONCOLOGY, INC.（CTOR）与CHICAGO RIVET & MACHINE CO（CVR）财务数据对比。点击上方公司名可切换其他公司
CHICAGO RIVET & MACHINE CO的季度营收约是CITIUS ONCOLOGY, INC.的1.5倍（$6.0M vs $3.9M），CHICAGO RIVET & MACHINE CO净利率更高（-19.3% vs -140.3%，领先121.0%）
Citius Oncology是一家处于后期阶段的生物制药企业，专注于开发针对癌症患者的创新靶向疗法，核心管线覆盖血液恶性肿瘤和实体瘤领域的未满足医疗需求，主要服务北美及全球肿瘤诊疗市场。
芝加哥气动（简称CP）是一家工业制造企业，主营动力工具、空气压缩机、发电机、照明灯塔及液压设备，产品通过全球分销网络销往150多个国家，业务覆盖工业生产工具、汽车维修、采矿维保检修、工程建设、基础设施设备等多个领域。
CTOR vs CVR — 直观对比
营收规模更大
CVR
是对方的1.5倍
$3.9M
净利率更高
CVR
高出121.0%
-140.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.9M | $6.0M |
| 净利润 | $-5.5M | $-1.2M |
| 毛利率 | 80.0% | 2.7% |
| 营业利润率 | -133.2% | -15.3% |
| 净利率 | -140.3% | -19.3% |
| 营收同比 | — | 45.9% |
| 净利润同比 | 16.9% | 68.0% |
| 每股收益（稀释后） | $-0.06 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTORCVR
| Q4 25 | $3.9M | $6.0M | ||
| Q3 25 | — | $7.4M | ||
| Q2 25 | — | $7.3M | ||
| Q1 25 | — | $7.2M | ||
| Q4 24 | — | $4.1M | ||
| Q3 24 | — | $7.0M | ||
| Q2 24 | — | $8.1M | ||
| Q1 24 | — | $7.9M |
净利润CTORCVR
| Q4 25 | $-5.5M | $-1.2M | ||
| Q3 25 | — | $67.6K | ||
| Q2 25 | — | $-395.0K | ||
| Q1 25 | — | $401.0K | ||
| Q4 24 | — | $-3.6M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $142.1K | ||
| Q1 24 | — | $-698.0K |
毛利率CTORCVR
| Q4 25 | 80.0% | 2.7% | ||
| Q3 25 | — | 18.1% | ||
| Q2 25 | — | 13.4% | ||
| Q1 25 | — | 22.9% | ||
| Q4 24 | — | -43.7% | ||
| Q3 24 | — | 10.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 9.5% |
营业利润率CTORCVR
| Q4 25 | -133.2% | -15.3% | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | — | -5.7% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | -86.4% | ||
| Q3 24 | — | -11.8% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | -11.5% |
净利率CTORCVR
| Q4 25 | -140.3% | -19.3% | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | — | -5.4% | ||
| Q1 25 | — | 5.5% | ||
| Q4 24 | — | -88.0% | ||
| Q3 24 | — | -20.8% | ||
| Q2 24 | — | 1.8% | ||
| Q1 24 | — | -8.9% |
每股收益（稀释后）CTORCVR
| Q4 25 | $-0.06 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $7.3M | $1.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $58.4M | $18.8M |
| 总资产 | $110.0M | $23.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTORCVR
| Q4 25 | $7.3M | $1.7M | ||
| Q3 25 | — | $1.7M | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $765.6K | ||
| Q4 24 | — | $2.2M | ||
| Q3 24 | — | $2.2M | ||
| Q2 24 | — | $2.6M | ||
| Q1 24 | — | $2.7M |
总债务CTORCVR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CTORCVR
| Q4 25 | $58.4M | $18.8M | ||
| Q3 25 | — | $20.0M | ||
| Q2 25 | — | $20.0M | ||
| Q1 25 | — | $20.4M | ||
| Q4 24 | — | $20.0M | ||
| Q3 24 | — | $23.7M | ||
| Q2 24 | — | $25.2M | ||
| Q1 24 | — | $25.2M |
总资产CTORCVR
| Q4 25 | $110.0M | $23.3M | ||
| Q3 25 | — | $24.0M | ||
| Q2 25 | — | $23.6M | ||
| Q1 25 | — | $24.1M | ||
| Q4 24 | — | $23.4M | ||
| Q3 24 | — | $26.4M | ||
| Q2 24 | — | $27.3M | ||
| Q1 24 | — | $27.8M |
负债/权益比CTORCVR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-7.4M | $116.4K |
| 自由现金流经营现金流 - 资本支出 | — | $24.3K |
| 自由现金流率自由现金流/营收 | — | 0.4% |
| 资本支出强度资本支出/营收 | — | 1.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.6M |
8季度趋势，按日历期对齐
经营现金流CTORCVR
| Q4 25 | $-7.4M | $116.4K | ||
| Q3 25 | — | $638.0K | ||
| Q2 25 | — | $28.2K | ||
| Q1 25 | — | $-2.0M | ||
| Q4 24 | — | $-60.1K | ||
| Q3 24 | — | $-58.2K | ||
| Q2 24 | — | $363.5K | ||
| Q1 24 | — | $-398.8K |
自由现金流CTORCVR
| Q4 25 | — | $24.3K | ||
| Q3 25 | — | $492.1K | ||
| Q2 25 | — | $-22.8K | ||
| Q1 25 | — | $-2.1M | ||
| Q4 24 | — | $-118.1K | ||
| Q3 24 | — | $-368.9K | ||
| Q2 24 | — | $58.0K | ||
| Q1 24 | — | $-491.8K |
自由现金流率CTORCVR
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 6.7% | ||
| Q2 25 | — | -0.3% | ||
| Q1 25 | — | -28.3% | ||
| Q4 24 | — | -2.9% | ||
| Q3 24 | — | -5.3% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | -6.3% |
资本支出强度CTORCVR
| Q4 25 | — | 1.5% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.8% | ||
| Q1 24 | — | 1.2% |
现金转化率CTORCVR
| Q4 25 | — | — | ||
| Q3 25 | — | 9.44× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -5.01× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 2.56× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTOR
暂无分部数据
CVR
| Fastener | $5.1M | 85% |
| Other | $890.7K | 15% |
